Results

Total Results: 2,463 records

Showing results for "testing".

41. Comparative Effectiveness of Fecal DNA Testing in Screening for Colorectal Cancer in Average-Risk Adults | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/colorectal-cancer-screening/research-protocol
    May 18, 2011 - Systematic Review May. 17, 2012 Disposition of Comments Report Comparative Effectiveness of Fecal DNA Testing … (FOBT) or fecal immunohistochemical testing (FIT) annually; and flexible sigmoidoscopy every 5 years … with or without fecal blood testing (FOBT or FIT). 3, 4 Some disagreement occurs between guideline … Question 6: Harms What are the potential harms of fecal DNA testing? … FOBT = Fecal Occult-Blood Testing USPSTF = U.S.

42. Topic Suggestion Description | Effective Health Care Program
    effectivehealthcare.ahrq.gov/get-involved/nominated-topics/key-questions-1-does-routine-preoperative-testing-compared-to-no-testing-or-alternative-testing-strategies-improve-outcomes-such-as-surgical-complications-other-morbidity-and-mortality-among-patients-undergoing-elective-surge
    February 10, 2011 - Key Questions Does routine preoperative testing compared to no testing or alternative testing strategies … What are the harms of routine preoperative testing compared to no testing or to an alternative testing … compared to no testing or alternative testing. … It is unclear why routine preoperative testing is still widespread. … It is unclear why routine preoperative testing is still widespread.

43. Effective Health Care (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0411_02-10-2011.pdf
    January 01, 2011 - 09-12-11 1 Results of Topic Selection Process & Next Steps  Routine preoperative testing … improves patient outcomes compared to patients receiving no preoperative testing or alternative testing … Does routine preoperative testing compared to no testing or alternative testing strategies improve outcomes … What are the harms of routine preoperative testing compared to no testing or to an alternative testing …  No recent comprehensive review related to preoperative testing in ambulatory surgery patients

44. Effective Health Care (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0334_08-04-2010.pdf
    January 01, 2010 - Date: 3-22-11 1 Results of Topic Selection Process & Next Steps  Pharmacogenetic testing … Intervention(s): Genetic testing for CYP2C19 variants to guide treatment selection. … Comparator(s): A no-testing (for CYP2C19 variants) strategy or a strategy of testing for Pharmacogenetic … who are candidates for clopidogrel treatment, compared to alternative testing strategies or a no-testing … strategies or a no- testing strategy?

45. Testing of CYP2C19 Variants and Platelet Reactivity for Guiding Antiplatelet Treatment | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/antiplatelet-treatment/research-protocol
    November 22, 2011 - Randomized trials of testing strategies versus no-testing strategies can address the question of whether … the use of testing (e.g., genetic testing to determine CYP2C19 status or phenotypic testing of platelet … Genetic testing for CYP2C19 Genetic testing for CYP2C19 followed by phenotypic testing for platelet … reactivity Phenotypic testing for platelet reactivity No testing How do modifying factors (e.g … Use of phenotypic testing (but not genetic testing) as a monitoring test can be considered as a variation

46. Effective Health Care Program
    effectivehealthcare.ahrq.gov/health-topics/lupus-0
    March 07, 2012 - March 7, 2012 Antinuclear Antibody, Rheumatoid Factor, and Cyclic-Citrullinated Peptide Testing

47. Prader-Willi Syndrome | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/health-topics/prader-willi-syndrome
    September 30, 2014 - Genetic Testing for Developmental and Intellectual Disabilities Research Protocol Archived

48. PCA3 Testing for the Diagnosis and Management of Prostate Cancer | Effective Health Care Program
    effectivehealthcare.ahrq.gov/products/prostate-cancer-test
    October 14, 2011 - PCA3 Testing for the Diagnosis and Management of Prostate Cancer Timeline May 04, 2011 … Initiated October 14, 2011 Research Protocol Archived PCA3 Testing … of Prostate Cancer April 01, 2013 Systematic Review Archived PCA3 Testing

49. Testing of CYP2C19 Variants and Platelet Reactivity for Guiding Antiplatelet Treatment | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/antiplatelet-treatment
    November 22, 2011 - Testing of CYP2C19 Variants and Platelet Reactivity for Guiding Antiplatelet Treatment … Topic Initiated November 22, 2011 Research Protocol Archived Testing … Antiplatelet Treatment September 25, 2013 Systematic Review Archived Testing

50. Neurologic Diseases | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/health-topics/neurologic-diseases
    May 20, 2013 - Treatments for Low Back Pain Consumer Summary Archived November 15, 2016 Noninvasive Testing … Coronary Artery Disease Systematic Review Archived March 29, 2016 Noninvasive Testing … ) Depression: A Systematic Review Research Protocol August 31, 2016 Genetic Testing … and Autism Spectrum Disorder Technical Brief Archived June 30, 2015 Genetic Testing

51. Methods Guide for Medical Test Reviews Chapter 3 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-tests-outcomes_methods.pdf
    July 01, 2012 - Direct health effects of testing Emotional, cognitive, social, behavioral re- sponses to testing … Legal, ethical effects of testing Costs Outcome Origins From Testing Process From Test Results … Legal and ethical effect of testing. … Legal and ethical effects of testing. … Legal and ethical effects of testing.

52. Testing a Machine Learning Tool for Facilitating Living Systematic Reviews of Chronic Pain Treatments | Effective Health Care Program
    effectivehealthcare.ahrq.gov/products/machine-learning-tool
    November 03, 2020 - Testing a Machine Learning Tool for Facilitating Living Systematic Reviews of Chronic Pain Treatments … 2020 Topic Initiated November 03, 2020 Research Report Testing

53. PCA3 Testing in the Diagnosis and Management of Prostate Cancer: Future Research Needs (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/prostate-cancer-antigen-3-gene_research.pdf
    April 01, 2013 - Patients with elevated PCA3 values PCA3 testing Current standard of care without PCA3 testing … aggressive therapy PCA3 testing Current standard of care without PCA3 testing Decision to biopsy … Patients with elevated PCA3 values PCA3 testing Current standard of care without PCA3 testing … or standard testing alone. … or standard testing alone.

54. Topic Suggestion Description | Effective Health Care Program
    effectivehealthcare.ahrq.gov/get-involved/nominated-topics/for-women-when-comparing-noninvasive-testingwhich-testing-method-echocardiography-mibi-spect-pharmacological-testing-etc-is-more-accurate-in-diagnosing-coronary-artery-disease-there-has-been-inadequate-studies-done-on-women-f
    April 10, 2009 - For women, when comparing noninvasive testing,which testing method (echocardiography, MIBI-SPECT, pharmacological … testing, etc.) is more accurate in diagnosing coronary artery disease. … Nuclear stress testing compared with echocardiographic stress testing has not been adequately compared … and risks associated with more invasive testing. … is needed for the newer stress testing methods and comparison of these methods.

55. Disposition of Comments Report for Testing of CYP2C19 Variants and Platelet Reactivity for Guiding Antiplatelet Treatment (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/antiplatelet-treatment_disposition-comments.pdf
    September 25, 2013 - for CYP2C19 variants and phenotypic testing for platelet reactivity, focusing on standardizing testing … This appears to be a very rigorous review of platelet function testing and CYP2C19 genetic testing for … We reviewed several studies comparing testing versus no-testing strategies for tests measuring platelet … Use of phenotypic testing (but not genetic testing) as a monitoring test can be considered a variation … Pharmacokinetic and pharmacodynamic testing (such as platelet function testing) in healthy volunteers

56. Topic 0451 Celiac Disease NSD FINAL (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND-533_05-24-2013.pdf
    January 01, 2013 - Testing … The current strategy for diagnosing CD involves serial serologic and histopathologic testing. … After initial evaluation and testing for iron, folate and vitamin B12 deficiencies and ruling out other … Objective 4 - Expected consequences of testing for CD (Celiac 4) a. … What are the expected consequences of testing for CD in the following populations: i.

57. Prognostic Tests (ppt file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/medical-test-reviews-prognostic.ppt
    June 01, 2012 - Setting Who will use the prognostic test; how the test will be used; what the applicable testing scenario … Cost-effectiveness: Do the improvements in patient outcomes justify the additional costs of testing and … Were the subjects somehow referred or selected for testing? What was the testing scenario? … The second question asks about the subject selection and testing scenario. … Subpart A asks about uniformity of testing across all sites or all studies being reported.

58. Prognostic Tests (ppt file)
    effectivehealthcare.ahrq.gov/sites/default/files/medical-test-reviews-prognostic.ppt
    June 01, 2012 - Setting Who will use the prognostic test; how the test will be used; what the applicable testing scenario … Cost-effectiveness: Do the improvements in patient outcomes justify the additional costs of testing and … Were the subjects somehow referred or selected for testing? What was the testing scenario? … The second question asks about the subject selection and testing scenario. … Subpart A asks about uniformity of testing across all sites or all studies being reported.

59. Disposition of Comments for Comparative Effectiveness Review 130 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/preoperative-testing_disposition-comments.pdf
    January 29, 2014 - vs non-testing. … versus not testing (or other protocols for testing). … routine or per protocol vs. ad hoc testing. … One of the key issues of preoperative testing is that more testing may be required in places less able … The study evaluates all preoperative testing.

60. PCA3 Testing for the Diagnosis and Management of Prostate Cancer | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/prostate-cancer-test/research-protocol
    October 14, 2011 - Research Protocol Apr. 1, 2013 Systematic Review Jul. 31, 2013 Disposition of Comments Report PCA3 Testing … These programs are based on the premise that PSA testing can lead to early detection of prostate cancer … However, testing total PSA levels to decide which patients should undergo a biopsy has been found to … by and used at a single laboratory testing site). … The Key Questions (KQs) present three proposed scenarios in which this testing may be used.